Stay updated with breaking news from Nkarta inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nkarta (NASDAQ:NKTX) Given New $13.00 Price Target at Needham & Company LLC dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Nkarta (NASDAQ:NKTX) PT Lowered to $15.00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Century Therapeutics unveils plans to expand CNTY-101 clinical development into additional autoimmune diseases, including systemic lupus erythematosus. $60 million private placement supports R&D activities. Acquisition of Clade Therapeutics enhances pipeline with iPSC-focused programs. ....
Glancy Prongay & Murray LLP , a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Nkarta, Inc. investors concerning the Company’s. ....
The Law Offices of Frank R. Cruz announces an investigation of Nkarta, Inc. on behalf of investors concerning the Company’s possible violations of federal securities laws.